SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-16-000025
Filing Date
2016-02-09
Accepted
2016-02-09 16:46:02
Documents
47
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311510q.htm 10-Q 750774
2 EXHIBIT 10.1 a123115ex101.htm EX-10.1 129016
3 EXHIBIT 10.2 a123115ex102.htm EX-10.2 871452
4 EXHIBIT 31.1 a123115ex311.htm EX-31.1 9403
5 EXHIBIT 31.2 a123115ex312.htm EX-31.2 9506
6 EXHIBIT 32.1 a123115ex321.htm EX-32.1 5621
7 EXHIBIT 32.2 a123115ex322.htm EX-32.2 5682
14 nelltanserinjpg.jpg GRAPHIC 1606
  Complete submission text file 0001636050-16-000025.txt   3576650

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT axon-20151231.xml EX-101.INS 254862
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20151231.xsd EX-101.SCH 27713
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20151231_cal.xml EX-101.CAL 39521
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20151231_def.xml EX-101.DEF 108934
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20151231_lab.xml EX-101.LAB 343342
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20151231_pre.xml EX-101.PRE 183574
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 161400585
SIC: 2834 Pharmaceutical Preparations